Harry H Yoon, MD

  • 1096 Citations
  • 18 Scopus h-Index
20032019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Harry H Yoon is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 12 Similar Profiles
Adenocarcinoma Medicine & Life Sciences
Esophagogastric Junction Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Esophageal Neoplasms Medicine & Life Sciences
DNA Mismatch Repair Medicine & Life Sciences
Survival Medicine & Life Sciences
Colonic Neoplasms Medicine & Life Sciences
erbB-2 Genes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2003 2019

A Comparison of Patient-Reported Health-Related Quality of Life During Proton Versus Photon Chemoradiation Therapy for Esophageal Cancer

Garant, A., Whitaker, T. J., Spears, G. M., Routman, D. M., Harmsen, W. S., Wilhite, T. J., Ashman, J. B., Sio, T. T., Rule, W. G., Neben Wittich, M. A., Martenson, J. A., Tryggestad, E. J., Yoon, H. H., Blackmon, S., Merrell, K. W., Haddock, M. & Hallemeier, C., Jan 1 2019, (Accepted/In press) In : Practical Radiation Oncology.

Research output: Contribution to journalArticle

Esophageal Neoplasms
Photons
Protons
Quality of Life
Therapeutics
1 Citation (Scopus)

Intertumoral heterogeneity of CD3þ and CD8þ T-cell densities in the microenvironment of DNA mismatch-repair–deficient colon cancers: Implications for prognosis

Yoon, H. H., Shi, Q. D., Heying, E. N., Muranyi, A., Bredno, J., Ough, F., Djalilvand, A., Clements, J., Bowermaster, R., Liu, W. W., Barnes, M., Alberts, S. R., Shanmugam, K. & Sinicrope, F. A., Jan 1 2019, In : Clinical Cancer Research. 25, 1, p. 125-133 9 p.

Research output: Contribution to journalArticle

DNA Mismatch Repair
Colonic Neoplasms
Cell Count
T-Lymphocytes
DNA
3 Citations (Scopus)

Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study

Bang, Y. J., Kang, Y. K., Catenacci, D. V., Muro, K., Fuchs, C. S., Geva, R., Hara, H., Golan, T., Garrido, M., Jalal, S. I., Borg, C., Doi, T., Yoon, H. H., Savage, M. J., Wang, J., Dalal, R. P., Shah, S., Wainberg, Z. A. & Chung, H. C., Jan 1 2019, In : Gastric Cancer.

Research output: Contribution to journalArticle

Open Access
Esophagogastric Junction
Combination Drug Therapy
Stomach
Adenocarcinoma
Therapeutics

A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer

Routman, D. M., Garant, A., Lester, S. C., Day, C. N., Harmsen, W. S., Sanheuza, C. T., Yoon, H. H., Neben-Wittich, M. A., Martenson, J. A., Haddock, M., Hallemeier, C. L. & Merrell, K. W., Jan 1 2018, (Accepted/In press) In : Advances in Radiation Oncology.

Research output: Contribution to journalArticle

Lymphopenia
Esophageal Neoplasms
Photons
Protons
Radiotherapy
2 Citations (Scopus)
Paclitaxel
Adenocarcinoma
Programmed Cell Death 1 Receptor
Drug Therapy
Esophagogastric Junction